Eczema Trial, Recruiting NCT05584488 Sponsor: Columbia University Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT05584488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any age (from newborns to 99 years old) who are known to have, or are suspected of having, an inherited condition related to allergies, mast cells (a type of immune cell), or problems with how the immune system is regulated
  • Blood relatives of people who are already enrolled in the trial
  • People of any age, gender, race, or with any disability are welcome to apply
  • People (or their parent/guardian) who are willing and able to give their consent to take part
  • People who agree to have their blood stored for future research into the immune system and other medical conditions

Who may not be able to join:

  • People who have a non-inherited (acquired) problem with their immune system — for example, those who have had chemotherapy or have a type of cancer — may not be able to join if the research team believes this would affect the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joshua D. Milner, MD, Columbia University

Phone: 212-305-2100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 July 2010
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total number of underlying susceptibility trait(s) identified

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov